Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-25-062437
Filing Date
2025-06-25
Accepted
2025-06-25 09:30:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM tm2518614d2_posam.htm POS AM 32774
  Complete submission text file 0001104659-25-062437.txt   33815
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-203292 | Film No.: 251071319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)